FDA Status
Discontinued (Geref)
Previously FDA-approved for pediatric GH deficiency; not withdrawn for safety
Claimed Benefits
- Growth hormone stimulation
- Pediatric growth support
- IGF-1 elevation in older adults
Clinical Evidence
5
Human Trials
Phase III
Highest Phase
Meaningful evidence base in pediatric GH deficiency and older adult endocrine studies, though no large RCTs demonstrate longevity endpoints.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations